Financial Statements

Bayer Group Consolidated Statements of Financial Position

			[Table 21]
	March 31, 2009	March 31, 2010	Dec. 31, 2009
	€ million	€ million	€ million
Noncurrent assets
Goodwill	8,649	8,906	8,704
Other intangible assets	13,520	12,684	12,842
Property, plant and equipment	9,596	9,634	9,409
Investments accounted for using the equity method	456	388	395
Other financial assets	1,374	1,373	1,200
Other receivables	425	537	549
Deferred taxes	1,212	1,212	950
	35,232	34,734	34,049
Current assets
Inventories	6,630	6,533	6,091
Trade accounts receivable	6,719	7,302	6,106
Other financial assets	423	240	367
Other receivables	1,110	1,333	1,357
Claims for income tax refunds	310	291	347
Cash and cash equivalents	4,365	3,041	2,725
Assets held for sale and discontinued operations	302	0	0
	19,859	18,740	16,993

Total assets	55,091	53,474	51,042

Equity
Capital stock of Bayer AG	1,957	2,117	2,117
Capital reserves of Bayer AG	4,028	6,167	6,167
Other reserves	11,034	11,278	10,613
Equity attributable to Bayer AG stockholders	17,019	19,562	18,897
Equity attributable to non-controlling interest	75	59	54
	17,094	19,621	18,951

Noncurrent liabilities
Provisions for pensions and other post-employment benefits	6,094	7,051	6,517
Other provisions	1,250	1,471	1,516
Financial liabilities	12,736	10,675	11,460
Other liabilities	332	417	415
Deferred taxes	3,576	3,120	3,210
	23,988	22,734	23,118
Current liabilities
Other provisions	3,538	3,779	3,089
Financial liabilities	6,287	2,680	1,489
Trade accounts payable	2,045	2,876	2,735
Income tax liabilities	113	74	93
Other liabilities	2,026	1,710	1,567
	14,009	11,119	8,973

Total equity and liabilities	55,091	53,474	51,042
2009 figures restated

http://www.stockholders-newsletter-q1-2010.bayer.com/en/financial-position.aspx

Copyright © Bayer AG